Zhang, P., Zhang, P., Xie, D., Xie, D., Li, Q., & Li, Q. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A.
Chicagoスタイル(17版)引用形式Zhang, Peng-Fei, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, , Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
MLA(9版)引用形式Zhang, Peng-Fei, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
警告: この引用は必ずしも正確ではありません.